EN
HI
Cipla Chart
Cipla Share Key Metrics
Volume
13.70 L
Market Cap
105786.96 CR
LTQ@LTP
1@1309.60
ATP
1314.58
Var Margin
12.5 %
Circuit Range
1185.9-1449.3
Delivery %
59.01 %
Value
180.14 CR
ASM/GSM
No
Market Lot
1
Summary
Cipla share price stands at ₹1309.6 at 30 Apr, 2026 | 15:47. The stock Cipla intraday movement has stayed between ₹1305.00 and ₹1329.80, while on a 52-week basis it has fluctuated from ₹1165.70 to ₹1673.00.
In terms of trading activity, Cipla has recorded a volume of 1370336 shares. The Cipla has a market cap of ₹807780677. The stock’s Average Traded Price (ATP) stands at ₹131458, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1, 130960.
The Cipla operates within a circuit range of ₹1185.9-1449.3 – ₹1185.9-1449.3, with a Value of ₹180.14 CR. The Delivery Percentage for the day is 59.01%. Additionally, Cipla currently falls under the No framework, and trades with a market lot size of 1.
Cipla Fundamentals
View MoreP/E Ratio
23.27
P/B Ratio
3.15
Div. Yield
1.22
Sector P/E
65.48
Sector P/B
3.5
Sec. Div. Yield
0.57
Cipla Resistance and Support
Pivot 1314.8
Resistance
First Resistance
1324.6
Second Resistance
1339.6
Third Resistance
1349.4
Support
First Support
1299.8
Second Support
1290
Third Support
1275
Cipla Futures & Options
Cipla Option Chain
View Price, OI, Greeks & More...
26MAY26
1315.00
-0.20 (0.02%)
30JUN26
1316.00
1.30 (0.10%)
28JUL26
1323.60
3.40 (0.26%)
CIPLA|26MAY26 CE 1300.00
48.40
1.1 (2.33%)
CIPLA|26MAY26 PE 1310.00
34.8
-0.8 (-2.25%)
Cipla Corporate Actions
| Date | Agenda |
|---|---|
| 2026-05-13 | Audited Results & Final Dividend |
| 2026-01-23 | Quarterly Results |
| 2025-10-30 | Quarterly Results |
| 2025-07-25 | Quarterly Results |
| 2025-05-13 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results |
Cipla News
Cipla Share Price Live Updates: Cipla's Market Performance Update
The live blog provides real-time updates on Cipla's stock performance, with the latest data showing shares trading at Rs 1306.5, a market capitalization of Rs 105536.8 crore, and a P/E ratio of 23.21 as of April 29, 2026.
Apr 29 2026 08:04:00
Stock Market Crash LIVE Updates: Nifty above 23,900; Hind Zinc profit up 68%
Cipla's stock recorded a gain of 5.56%, closing at ₹1,305.00, as observed in live market statistics.
Apr 24 2026 14:04:00
Read More
About Cipla
NSE : 694
BSE : 500087
ISIN : INE059A01026
Cipla Management
| Name | Position |
|---|---|
| Y K Hamied | Chairman |
| Kamil Hamied | Non Independent & Non Executive Director |
Cipla Similar Stocks
Sun Pharmaceutical Industries Ltd.
1808.30
0.00 (0.00%)
Divi's Laboratories Ltd.
6502.50
0.00 (0.00%)
Torrent Pharmaceuticals Ltd.
4185.10
0.00 (0.00%)
Dr. Reddy's Laboratories Ltd.
1322.90
0.00 (0.00%)
Apollo Hospitals Enterprise Ltd.
7636.50
0.00 (0.00%)
Lupin Ltd.
2305.20
0.00 (0.00%)
Max Healthcare Institute Ltd.
993.05
0.00 (0.00%)
Mankind Pharma Ltd.
2246.70
0.00 (0.00%)
Zydus Lifesciences Ltd.
891.90
0.00 (0.00%)
Lenskart Solutions Ltd.
515.95
0.00 (0.00%)
Cipla FAQs
The Buying Price of Cipla share is 1309.6 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cipla stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cipla, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cipla shares is 23.27. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cipla shares is 3.15. Useful to assess the stock's value relative to its book value.
To assess Cipla’s valuation compare Sector P/E, P/B which are 65.48 & 3.5 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cipla is 105786.96 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cipla share price is 1673.00 & 1165.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cipla belongs to the Healthcare sector.
